MINIMAL EFFECTS OF ESCHERICHIA-COLI AND ERWINIA ASPARAGINASE ON THE COAGULATION SYSTEM IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED STUDY

被引:24
作者
RISSEEUWAPPEL, IM [1 ]
DEKKER, I [1 ]
HOP, WCJ [1 ]
HAHLEN, K [1 ]
机构
[1] ERASMUS UNIV ROTTERDAM,DEPT BIOSTAT,3000 DR ROTTERDAM,NETHERLANDS
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1994年 / 23卷 / 04期
关键词
ALL; CHILDHOOD; ESCHERICHIA-COLI ASPARAGINASE; ERWINIA ASPARAGINASE; COAGULATION;
D O I
10.1002/mpo.2950230404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A randomized study was done in twenty newly diagnosed children with acute lymphoblastic leukemia. Ten children were treated with Escherichia coli L-asparaginase, and ten with Erwinia chrysanthemi L-asparaginase. L-asparaginase (ASP) treatment started halfway during ALL-induction treatment with vincristine, prednisone, daunorubicine and intrathecal methotrexate. The mean activated partial thromboplastin time (APTT) level in all children demonstrated a significant fall (P < 0.001) from 28.25 sec at diagnosis to 23.0 sec at the start of ASP treatment. In this same time interval, the mean fibrinogen level declined markedly from 3 g/l to 1.2 g/l (P < 0.001), probably due to prednisone therapy. The APTT stayed shortened during ASP therapy, whereas the hypofibrinogenemia recovered significantly faster in the Erwinia group (P less-than-or-equal-to 0.01). Factors (F) II, V, VII and X stayed within the normal range, while F VIII and F IX were elevated. During the entire period of induction therapy, the ATIII activity remained within the normal range in both treatment groups. The protein C values, however, demonstrated a steady decline from 140% at start of ASP treatment to a mean of 81% and 93%, respectively, at the end of the ASP therapy in the E. coli and Erwinia group. Five of the ten children treated with E. coli ASP demonstrated protein C levels below 70% at the end of ASP therapy, opposed to none of the Erwinia treated patients (P = 0.03). We suggest that the effect of ASP resulting in decreased coagulationfactor synthesis is in part counterbalanced by the effect of prednisone on the coagulation system, when ASP is administered at the end of ALL induction treatment. The overall effect of ASP either of E. coli or of Erwinia on the hemorrhagic system reveals a slight imbalance towards thrombosis, mainly because of a gradual decrease in protein C activity. This imbalance is less pronounced in the Erwinia group. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:335 / 343
页数:9
相关论文
共 39 条
[1]  
ALMONDHIRY H, 1975, CANCER-AM CANCER SOC, V35, P144, DOI 10.1002/1097-0142(197501)35:1<144::AID-CNCR2820350120>3.0.CO
[2]  
2-4
[3]   EFFECT OF L-ASPARAGINASE THERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA ON PLASMA VITAMIN-K-DEPENDENT COAGULATION-FACTORS AND INHIBITORS [J].
BEZEAUD, A ;
DROUET, L ;
LEVERGER, G ;
GRIFFIN, JH ;
GUILLIN, MC .
JOURNAL OF PEDIATRICS, 1986, 108 (05) :698-701
[4]  
BUCHANAN GR, 1980, MED PEDIATR ONCOL, V8, P7, DOI 10.1002/mpo.2950080103
[5]   INTRA-CRANICAL HEMORRHAGE AND FOCAL SEIZURES SECONDARY TO USE OF L-ASPARAGINASE DURING INDUCTION THERAPY OF ACUTE LYMPHOCYTIC-LEUKEMIA [J].
CAIRO, MS ;
LAZARUS, K ;
GILMORE, RL ;
BAEHNER, RL .
JOURNAL OF PEDIATRICS, 1980, 97 (05) :829-833
[6]  
CAIRO MS, 1982, AM J PEDIAT HEMATOL, V4, P335
[7]   L-ASPARAGINASE - CLINICAL, BIOCHEMICAL, PHARMACOLOGICAL, AND IMMUNOLOGICAL STUDIES [J].
CAPIZZI, RL ;
BERTINO, JR ;
SKEEL, RT ;
CREASEY, WA ;
ZANES, R ;
OLAYON, C ;
PETERSON, RG ;
HANDSCHUMACHER, RE .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (06) :893-+
[8]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[9]  
DANGELO SV, 1990, THROMB RES, V59, P985
[10]  
DURDEN DL, 1983, CANCER RES, V43, P1602